Cardlytics (CDLX) Tops Q4 EPS by 37c

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.05), $0.37 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $90 million versus the consensus estimate of $76.58 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
• KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty